Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms

Abstract In this study, bupivacaine (BUP) and meloxicam (MLX) were simultaneously assayed in their co-formulated ampoules without interference using four affordable, sensitive, and eco-friendly spectrophotometric methods. The assay of MLX at 359.3 nm over the concentration range of 1.0–15.0 µg/mL wa...

Full description

Saved in:
Bibliographic Details
Main Authors: Aya Saad Radwan, Mohamed M. Salim, Fathalla Belal, Galal Magdy
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-77562-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333402536247296
author Aya Saad Radwan
Mohamed M. Salim
Fathalla Belal
Galal Magdy
author_facet Aya Saad Radwan
Mohamed M. Salim
Fathalla Belal
Galal Magdy
author_sort Aya Saad Radwan
collection DOAJ
description Abstract In this study, bupivacaine (BUP) and meloxicam (MLX) were simultaneously assayed in their co-formulated ampoules without interference using four affordable, sensitive, and eco-friendly spectrophotometric methods. The assay of MLX at 359.3 nm over the concentration range of 1.0–15.0 µg/mL was accomplished using a direct UV-spectrophotometric method (Method I) without interference from BUP. However, there was a significant overlap between the spectra of BUP and MLX, making it difficult to determine BUP directly from the UV spectrum. Therefore, various UV-based techniques, including second derivative spectrophotometry (Method II), ratio subtraction method (Method III), and absorption factor method (Method IV), were used to determine BUP over the concentration range of 5.0–80.0 µg/mL. The proposed methods could simultaneously determine the studied drugs with a challenging ratio of 33.3:1.0 (BUP: MLX), which increases the importance of the current study. The proposed methods were applied to estimate the studied drugs in commercial ampoules with high % recoveries and low %RSD values. The excellent eco-friendliness of the developed methods was demonstrated using GAPI and AGREE metrics. The developed methods were validated according to ICHQ2(R2) guidelines. The proposed methods can be better suited for the routine analysis of BUP and MLX in their fixed-dose combination with high selectivity.
format Article
id doaj-art-75d9c5bd55fd4f3ba7f4b0679a2e2a0f
institution Kabale University
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-75d9c5bd55fd4f3ba7f4b0679a2e2a0f2025-08-20T03:45:52ZengNature PortfolioScientific Reports2045-23222024-11-0114111110.1038/s41598-024-77562-9Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage formsAya Saad Radwan0Mohamed M. Salim1Fathalla Belal2Galal Magdy3Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-EgyptDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-EgyptPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura UniversityPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Kafrelsheikh UniversityAbstract In this study, bupivacaine (BUP) and meloxicam (MLX) were simultaneously assayed in their co-formulated ampoules without interference using four affordable, sensitive, and eco-friendly spectrophotometric methods. The assay of MLX at 359.3 nm over the concentration range of 1.0–15.0 µg/mL was accomplished using a direct UV-spectrophotometric method (Method I) without interference from BUP. However, there was a significant overlap between the spectra of BUP and MLX, making it difficult to determine BUP directly from the UV spectrum. Therefore, various UV-based techniques, including second derivative spectrophotometry (Method II), ratio subtraction method (Method III), and absorption factor method (Method IV), were used to determine BUP over the concentration range of 5.0–80.0 µg/mL. The proposed methods could simultaneously determine the studied drugs with a challenging ratio of 33.3:1.0 (BUP: MLX), which increases the importance of the current study. The proposed methods were applied to estimate the studied drugs in commercial ampoules with high % recoveries and low %RSD values. The excellent eco-friendliness of the developed methods was demonstrated using GAPI and AGREE metrics. The developed methods were validated according to ICHQ2(R2) guidelines. The proposed methods can be better suited for the routine analysis of BUP and MLX in their fixed-dose combination with high selectivity.https://doi.org/10.1038/s41598-024-77562-9BupivacaineMeloxicamSpectrophotometryGreenness
spellingShingle Aya Saad Radwan
Mohamed M. Salim
Fathalla Belal
Galal Magdy
Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms
Scientific Reports
Bupivacaine
Meloxicam
Spectrophotometry
Greenness
title Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms
title_full Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms
title_fullStr Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms
title_full_unstemmed Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms
title_short Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms
title_sort eco friendly four spectrophotometric approaches for the simultaneous determination of the recently fda approved combination bupivacaine and meloxicam in pharmaceutical dosage forms
topic Bupivacaine
Meloxicam
Spectrophotometry
Greenness
url https://doi.org/10.1038/s41598-024-77562-9
work_keys_str_mv AT ayasaadradwan ecofriendlyfourspectrophotometricapproachesforthesimultaneousdeterminationoftherecentlyfdaapprovedcombinationbupivacaineandmeloxicaminpharmaceuticaldosageforms
AT mohamedmsalim ecofriendlyfourspectrophotometricapproachesforthesimultaneousdeterminationoftherecentlyfdaapprovedcombinationbupivacaineandmeloxicaminpharmaceuticaldosageforms
AT fathallabelal ecofriendlyfourspectrophotometricapproachesforthesimultaneousdeterminationoftherecentlyfdaapprovedcombinationbupivacaineandmeloxicaminpharmaceuticaldosageforms
AT galalmagdy ecofriendlyfourspectrophotometricapproachesforthesimultaneousdeterminationoftherecentlyfdaapprovedcombinationbupivacaineandmeloxicaminpharmaceuticaldosageforms